Relapsed or refractory extracranial solid tumors in children and adolescents. research hub

Feasibility clinical trial of the combination of AloCelyvir with chemotherapy and radiotherapy for the treatment of children and adolescents with relapsed or refractory extracranial solid tumors.

This study looks at a new treatment called AloCelyvir, combined with usual chemotherapy and radiotherapy, for young people (aged 18 and older) with cancer outside the brain that has come back or not responded to previous treatments. It aims to find the safest dose.